Evidence map›Paper›PMID 22385210›Full record

Trial reportDrug and alcohol review2013

Cigarette smoking as a target for potentiating outcomes for methamphetamine abuse treatment.

Matthew Brensilver, Keith G Heinzerling, Aimee-Noelle Swanson, Donatello Telesca, Benjamin A Furst, Steven J Shoptaw

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol review, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Efficacy of psychostimulant drugs for amphetamine abuse or dependence.The Cochrane database of systematic reviews · 2013
    Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Matthew BrensilverDepartment of Family Medicine, David Geffen School of Medicine at UCLA, Los Angeles, USA. mbrensilver@mednet.ucla.edu
Keith G Heinzerling
Aimee-Noelle Swanson
Donatello Telesca
Benjamin A Furst
Steven J Shoptaw
University of California, Los Angeles · USUCLA Medical Center · US

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RAPHAEL J LANDOVITZ · 1997 to 2026
$53.5M
UCLA Medication Development Unit for Stimulant AbuseP50DA018185 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SHOPTAW, STEVEN J · 2004 to 2009
$5.8M
UCLA Training Program on Addiction Medicine in Primary CareT32DA026400 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SHOPTAW, STEVEN J · 2009 to 2013
$1.3M
NIDA NIH HHS P50 DA018185NIDA NIH HHS P50 DA18185NIDA NIH HHS T32 DA026400NIMH NIH HHS P30 MH058107
6 · The paper itself

Abstract

INTRODUCTION AND

aimsCigarette smoking occurs frequently among individuals with methamphetamine (MA) dependence. Preclinical and clinical evidence has suggested that the common co-abuse of MA and cigarettes represents a pharmacologically meaningful pattern.

methodsThe present study is a secondary analysis of a randomised, placebo-controlled trial of bupropion treatment for MA dependence (bupropion n = 36; placebo n = 37). A hierarchical logistic modelling approach assessed the efficacy of bupropion for reducing MA use separately among smokers and non-smokers. Among smokers, relations between cigarettes smoked and MA use were assessed.

resultsSmoking status did not affect treatment responsiveness in either the bupropion condition or the placebo condition. In the placebo condition, increased cigarette use was associated with an increased probability of MA use during the same time period. This effect was not observed in the bupropion condition. DISCUSSION AND

conclusionsInitial smoking status did not impact treatment outcomes. Among smokers, results suggest that bupropion may dissociate cigarette and MA use. The effect was modest and a precise pharmacological mechanism remains elusive. Cholinergic systems may be relevant for MA use outcomes. Future studies should continue to assess the role of smoking in MA treatment outcomes.

Indexed as

MethamphetamineAdultAmphetamine-Related DisordersBupropionCognitive Behavioral TherapyDouble-Blind MethodFemaleHumansMaleSmokingSmoking CessationTreatment OutcomeBupropionMethamphetamine

Identifiers

PMID22385210
PMCPMC3371287
OpenAlexW1949947453

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.